Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.

Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
复制标题

DOI:
--
复制
发表时间:
1998-02
期刊:
The American journal of pathology
影响因子:
--
通讯作者:
M. Gerritsen;C. Shen;C. Perry
M. Gerritsen;C. Shen;C. Perry
中科院分区:
其他
文献类型:
--
作者:
M. Gerritsen;C. Shen;C. Perry

文献摘要

被引文献

相似文献

鞘磷脂酶的激活和神经酰胺的产生被认为是通过其第二信使神经酰胺介导肿瘤坏死因子- α (tnf - α)诱导的核因子(NF)-kappaB活化。神经酰胺也可能是细胞生长、衰老和凋亡的重要调节因子。异常的细胞增殖和凋亡与类风湿关节炎的成纤维细胞增殖和膜形成有关。然而,tnf - α和鞘磷脂酶途径在这一过程中的作用尚未确定。本研究的目的是确定tnf - α是否激活人滑膜成纤维细胞(HSF)的鞘磷脂通路,以及神经酰胺在HSF增殖和凋亡中的潜在作用。培养的人滑膜成纤维细胞受到外源性tnf - α、鞘磷脂酶和神经酰胺的刺激。细胞形态学和膜联蛋白V标记法检测细胞凋亡。免疫印迹法检测NF-kappaB和应激激酶通路激活情况。通过定量测定[14C]丝氨酸预标记HSF细胞中的鞘磷脂和神经酰胺放射性来测定鞘磷脂酶的活化。向HSF中添加tnf - α (50 ng/ml)未引起可检测到的鞘磷脂酶激活。tnf - α被证明可以激活NF-kappaB (p65易位和IkappaBalpha的降解)和应激激酶途径(ATF-2、p38和c-jun的磷酸化)。相比之下,外源性神经酰胺对这些信号通路没有影响,也没有刺激白细胞介素-6或白细胞介素-8的产生。高浓度的神经酰胺(>或=25微mol/L)具有细胞毒性,而较低浓度的神经酰胺抑制细胞周期进程。因此,尽管tnf - α刺激HSF中的NF-kappaB和应激激酶通路,但tnf - α的这些作用与鞘磷脂酶转换或诱导细胞凋亡无关。
The activation of sphingomyelinase and the generation of ceramide has been proposed to mediate tumor necrosis factor-alpha (TNF-alpha)-induced nuclear factor (NF)-kappaB activation through its second messenger ceramide. Ceramide may also be an important regulator of cell growth, senescence, and apoptosis. Aberrant cell proliferation and apoptosis have been implicated in the rampant fibroblast proliferation and pannus formation characteristic of rheumatoid arthritis. However, the role of TNF-alpha and the sphingomyelinase pathway in the process have not been determined. The objective of this study was to determine whether TNF-alpha activates the sphingomyelin pathway in human synovial fibroblasts (HSF) and the potential role of ceramide in HSF proliferation and apoptosis. Cultured human synovial fibroblasts were stimulated with exogenous TNF-alpha, sphingomyelinase, and ceramide. Apoptosis was assessed by cell morphology and annexin V labeling. NF-kappaB and stress kinase pathway activation were determined by immunoblotting techniques. Sphingomyelinase activation was determined by quantitation of sphingomyelin and ceramide radioactivity in [14C]serine-prelabeled HSF cells. The addition of TNF-alpha (50 ng/ml) to HSF did not elicit detectable sphingomyelinase activation. TNF-alpha was shown to activate NF-kappaB (p65 translocation and degradation of IkappaBalpha) and the stress kinase pathway (phosphorylation of ATF-2, p38, and c-jun). In contrast, exogenous ceramide had no effect on these signaling pathways nor did ceramide stimulate the generation of interleukin-6 or interleukin-8. High concentrations of ceramide (> or =25 micromol/L) were cytotoxic, whereas lower concentrations of ceramide inhibited cell cycle progression. Thus, although TNF-alpha stimulates the NF-kappaB and stress kinase pathways in HSF, these effects of TNF-alpha are not associated with sphingomyelinase turnover or induction of apoptosis.